Latest News

Flaw in Alzheimer's drug trial test, research suggests

New research suggests that the cognitive test used in Alzheimer's drug trials is flawed. They believe that the flaw lies behind the failure and withdrawal of a number of trials around the world, and they call for the current test to be replaced with a method that is fit for purpose.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • With racial segregation declining between neighborhoods, segregation now taking new form

  • Gene variants modifying Huntington's symptom onset may lead to new therapeutic strategies

  • Prescription for medical students: A day at the art museum?

  • Aquariums deliver health and wellbeing benefits

  • Teaching med students about health disparities builds their confidence

  • Antibiotics increase risk of hearing loss in patients with deadly bacterial infections

  • Changing clocks, changing seasons: Scientists find role for neuronal plasticity

  • Genetic tug of war in the brain influences parental control over offspring behavior

  • Generally accepted tools used to select patients for aneurysm treatment in need of further evaluation

  • Analysis of post deployment health assessment forms indicates risks of alcohol abuse among service members returning from deployment

  •